Digestive Tolerance of Maltitol and FOS
Digestive Tolerance and Postprandial Glycaemic and Insulinaemic Responses Evaluation of Different Maltitol/FOS Mixtures in Healthy Adults
1 other identifier
interventional
36
1 country
1
Brief Summary
Digestive symptoms following consumption of low digestibe carbohydrates are generally assessed product by product but several ingredients can be used simultaneously. The study aimed at evaluating to digestive tolerance of maltitol and FOS used in a same food.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2012
CompletedFirst Submitted
Initial submission to the registry
July 24, 2013
CompletedFirst Posted
Study publicly available on registry
July 26, 2013
CompletedJuly 26, 2013
July 1, 2013
1 year
July 24, 2013
July 25, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Composite score of gastrointestinal symptoms in the 24h following the consumption of products
24 hours
Secondary Outcomes (3)
Individual scores of gastrointestinal symptoms: bloating, abdominal discomfort, borborygms, flatulences
24 and 48 hours
Stool frequcency and consistency
24 & 48 hours
Glycaemic response
2 hours
Study Arms (6)
sugary dessert cream
PLACEBO COMPARATORmaltitol alone
EXPERIMENTALmaltitol 85% / FOS 15%
EXPERIMENTALmaltitol 68% / FOS 32%
EXPERIMENTALmaltitol 50% / FOS 50%
EXPERIMENTALFOS alone
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- BMI between 18.5 and 30
- normal and regular stool frequency: at least 3 stools per week and no more than 3 per days
- subjects not sufferinf from a metabolic, functional or inflammatory disease affecting intestinal transit and nutrients absorption
- subjects not sufferinf from IBS according to Rome III criteria
- subjects not using mdeiction which could affect nutrients absoprtion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Syrallead
- Beghin-Meijicollaborator
Study Sites (1)
Biofortis SAS
Saint-Herblain, 44800, France
MeSH Terms
Interventions
Study Officials
- PRINCIPAL INVESTIGATOR
David Gendre, MD
Biofortis SAS
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 24, 2013
First Posted
July 26, 2013
Study Start
September 1, 2011
Primary Completion
September 1, 2012
Study Completion
November 1, 2012
Last Updated
July 26, 2013
Record last verified: 2013-07